What is Tectonic Therapeutics's PP&E sale proceeds?

Tectonic Therapeutics (TECX) reported PP&E sale proceeds of $15K in Q3 2025.

What does PP&E sale proceeds mean?

Cash received from selling property, plant, and equipment no longer needed for operations.

Opko HealthOPK

$33K-50.7%

Operating income-$27.3M-49.2%

Net income-$25.2M-58.7%

EPS (diluted)-$1.34-44.1%

Cash & equivalents$236.9M-22.8%

Total debt$4.9M+86.1%

Total equity$230.4M-23.5%

Total assets$246.6M-21.7%

Operating cash flow-$18.4M-40.7%

CapEx$19.0K-29.6%

Free cash flow-$18.4M-40.6%

Market cap$585.51M+58.3%

Enterprise value$353.51M+438%

Return on equity-31.4%—

Debt / equity0×0.0×

Current ratio18.5×-4.4×

Reported directly by Tectonic Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment.

The official record: Tectonic Therapeutics’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Tectonic Therapeutics's PP&E sale proceeds?: Tectonic Therapeutics (TECX) reported PP&E sale proceeds of $15K in Q3 2025.
What does PP&E sale proceeds mean?: Cash received from selling property, plant, and equipment no longer needed for operations.